Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, have an estimated market size of US$ 177 million for twelve months ending Sep 2022
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
WHO made a strong recommendation for nirmatrelvir and ritonavir for mild and moderate COVID-19 patients at highest risk of hospital admission
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Japan’s Ministry of Health, Labour and Welfare (MHLW) has recently approved AstraZeneca's long-acting antibody combination “Evusheld” for the prevention ) and treatment of COVID-19.
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
